Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,568
Closed -$203K 254
2025
Q2
$203K Sell
2,568
-807
-24% -$64.1K 0.07% 236
2025
Q1
$303K Sell
3,375
-714
-17% -$66.7K 0.12% 166
2024
Q4
$407K Sell
4,089
-406
-9% -$41.9K 0.15% 142
2024
Q3
$510K Sell
4,495
-286
-6% -$34K 0.19% 113
2024
Q2
$592K Sell
4,781
-1,135
-19% -$146K 0.25% 88
2024
Q1
$781K Buy
5,916
+342
+6% +$42.2K 0.3% 71
2023
Q4
$608K Sell
5,574
-215
-4% -$22.3K 0.24% 89
2023
Q3
$596K Sell
5,789
-10,350
-64% -$1.12M 0.28% 80
2023
Q2
$1.86M Buy
16,139
+11,247
+230% +$1.28M 0.79% 22
2023
Q1
$520K Buy
4,892
+92
+2% +$9.93K 0.24% 98
2022
Q4
$533K Buy
4,800
+332
+7% +$33.9K 0.26% 95
2022
Q3
$385K Buy
4,468
+206
+5% +$18.4K 0.21% 106
2022
Q2
$389K Sell
4,262
-24
-0.6% -$2.13K 0.21% 114
2022
Q1
$352K Sell
4,286
-401
-9% -$31.6K 0.15% 144
2021
Q4
$359K Buy
4,687
+544
+13% +$43.3K 0.14% 154
2021
Q3
$311K Buy
4,143
+810
+24% +$61.6K 0.13% 166
2021
Q2
$259K Sell
3,333
-3,651
-52% -$272K 0.06% 208
2021
Q1
$514K Buy
6,984
+566
+9% +$41.8K 0.11% 188
2020
Q4
$500K Buy
6,418
+685
+12% +$52.4K 0.13% 185
2020
Q3
$454K Buy
+5,733
New +$449K 0.12% 174
2020
Q2
Sell
-5,334
Closed -$392K 259
2020
Q1
$392K Buy
5,334
+122
+2% +$9.59K 0.11% 130
2019
Q4
$452K Buy
+5,212
New +$428K 0.12% 134

Other funds holding MRK

Veracity Capital's MRK Position: Q3 2025 in Review

Veracity Capital sold out of Merck (MRK) in Q3 2025, closing a stake of 2,568 shares — an estimated $203K sold.

Veracity Capital first reported a position in MRK in Q4 2019 and held it in 22 quarters. The position peaked at $1.86M in Q2 2023. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Veracity Capital reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Veracity Capital sold 2,568 Merck shares in Q3 2025, an estimated $203K.
  • Veracity Capital first reported a position in Merck in Q4 2019 and held it in 22 quarters.
  • Veracity Capital's Merck position peaked at $1.86M in Q2 2023.
  • 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Veracity Capital's 13F filing for Q3 2025, filed 8 Oct 2025.